NEXGEL, INC. Long-Term Debt, Maturity, Year One
NEXGEL, INC. (NXGL) had Long-Term Debt, Maturity, Year One of $106.00 thousand as of 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths · last filed 2026-05-14
- 2026-03-31: Long-Term Debt, Maturity, Year One $106.00K.
- 2025-12-31: Long-Term Debt, Maturity, Year One $99.00K.
- 2025-09-30: Long-Term Debt, Maturity, Year One $96.00K.
- 2025-06-30: Long-Term Debt, Maturity, Year One $96.00K.
| Period end | Long-Term Debt, Maturity, Year One |
|---|---|
| 2026-03-31 | $106.00K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $99.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | $96.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $96.00K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $96.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $96.00K 10-K · filed 2025-03-27 |
| 2024-09-30 | $26.00K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $49.00K 10-Q · filed 2024-08-19 |
| 2024-03-31 | $69.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $80.00K 10-K · filed 2024-04-10 |
| 2023-09-30 | $5.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $5.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $5.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $5.00K 10-K · filed 2023-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |